BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26213186)

  • 1. Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients.
    Rager O; Baskin A; Amzalag G; Buchegger F; Miralbell R; Ratib O; Zilli T; Garibotto V
    Nuklearmedizin; 2015; 54(5):211-6. PubMed ID: 26213186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study.
    Beheshti M; Vali R; Waldenberger P; Fitz F; Nader M; Loidl W; Broinger G; Stoiber F; Foglman I; Langsteger W
    Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1766-74. PubMed ID: 18465129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.
    Kwee SA; Wei H; Sesterhenn I; Yun D; Coel MN
    J Nucl Med; 2006 Feb; 47(2):262-9. PubMed ID: 16455632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of bronchioloalveolar cancer by means of PET/CT and 18F-fluorocholine, and comparison with 18F-fluorodeoxyglucose.
    Balogova S; Huchet V; Kerrou K; Nataf V; Gutman F; Antoine M; Ruppert AM; Prignon A; Lavolée A; Montravers F; Mayaud C; Cadranel J; Talbot JN
    Nucl Med Commun; 2010 May; 31(5):389-97. PubMed ID: 20145579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer.
    Beauregard JM; Williams SG; Degrado TR; Roselt P; Hicks RJ
    J Med Imaging Radiat Oncol; 2010 Aug; 54(4):325-32. PubMed ID: 20718912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body 18F-fluorocholine (FCH) PET/CT and MRI of the spine for monitoring patients with castration-resistant prostate cancer metastatic to bone: a pilot study.
    Balogova S; Zakoun JB; Michaud L; Khalil A; Tassart M; Esteso A; Kerrou K; Huchet V; Carette MF; Lotz JP; Talbot JN
    Clin Nucl Med; 2014 Nov; 39(11):951-9. PubMed ID: 25140552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading.
    Langsteger W; Balogova S; Huchet V; Beheshti M; Paycha F; Egrot C; Janetschek G; Loidl W; Nataf V; Kerrou K; Pascal O; Cussenot O; Talbot JN
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):448-57. PubMed ID: 21738117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State of the art of PET/CT with 11-choline and 18F-fluorocholine in the diagnosis and follow-up of localized and locally advanced prostate cancer.
    Vagnoni V; Brunocilla E; Bianchi L; Porreca A; Borghesi M; Pultrone CV; Angelo P; Chessa F; Ceci F; Mengoni F; Dababneh H; Castellucci P; Fanti S; Martorana G; Schiavina R
    Arch Esp Urol; 2015 Apr; 68(3):354-70. PubMed ID: 25948806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual lymph node metastases of prostate cancer detected by 18F-fluorocholine PET/CT.
    Pinaquy JB; Allard JB; Cornelis F; Pasticier G; De Clermont H
    Clin Nucl Med; 2015 Apr; 40(4):e255-7. PubMed ID: 25674860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of unexpected additional primary malignancies with PET/CT.
    Ishimori T; Patel PV; Wahl RL
    J Nucl Med; 2005 May; 46(5):752-7. PubMed ID: 15872346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
    Tuncel M; Souvatzoglou M; Herrmann K; Stollfuss J; Schuster T; Weirich G; Wester HJ; Schwaiger M; Krause BJ
    Nucl Med Biol; 2008 Aug; 35(6):689-95. PubMed ID: 18678354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-positive result in 18F-fluorocholine PET/CT due to incidental and ectopic parathyroid hyperplasia.
    Cazaentre T; Clivaz F; Triponez F
    Clin Nucl Med; 2014 Jun; 39(6):e328-30. PubMed ID: 24152627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-11 choline PET/CT imaging for differentiating malignant from benign prostate lesions.
    Li X; Liu Q; Wang M; Jin X; Liu Q; Yao S; Liu S; Li J
    Clin Nucl Med; 2008 Oct; 33(10):671-6. PubMed ID: 18806565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study.
    Gillebert Q; Huchet V; Rousseau C; Cochet A; Olivier P; Courbon F; Gontier E; Nataf V; Balogova S; Talbot JN;
    PLoS One; 2018; 13(2):e0191487. PubMed ID: 29425221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid lymphoma incidentally detected by 18F-fluorocholine (FCH) PET/CT.
    Eccles A; Challapalli A; Khan S; Barwick T; Mangar S
    Clin Nucl Med; 2013 Sep; 38(9):755-7. PubMed ID: 23856826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of a second primary cancer in a 18F-fluorocholine PET/CT - multicentre retrospective analysis on a group of 1345 prostate cancer patients.
    Cegla P; Scibisz-Dziedzic K; Witkowska K; Kubiak A; Wierzchoslawska E; Kycler W; Chrapko B; Czepczyński R
    Nucl Med Rev Cent East Eur; 2022; 25(1):25-30. PubMed ID: 35137934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer localization with 18fluorine fluorocholine positron emission tomography.
    Kwee SA; Coel MN; Lim J; Ko JP
    J Urol; 2005 Jan; 173(1):252-5. PubMed ID: 15592091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic metastasis to cricoid from prostate carcinoma: an incidental finding detected on 18F-choline PET/CT.
    Ng SJ; Sinha AK; Loi HY; Khor LK
    Jpn J Radiol; 2015 May; 33(5):298-301. PubMed ID: 25820451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance.
    Israel O; Yefremov N; Bar-Shalom R; Kagana O; Frenkel A; Keidar Z; Fischer D
    J Nucl Med; 2005 May; 46(5):758-62. PubMed ID: 15872347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.